Prolonged Remission in Multiple Relapsed MLL-rearranged Infant B-ALL with Inotuzumab OzogamicinAkhila Lattupally MD1, Adonis Lorenzana MD1, Gregory Anthony Yanik MD2, Danielle Bell MD1,31. Ascension St. John Children’s Hospital, Detroit, Michigan, United States.2. C.S. Mott Children’s Hospital – University of Michigan, Ann Arbor, Michigan, United States.3. Children’s Hospital of Michigan, Detroit, Michigan, United States.Corresponding Author: Akhila Lattupally MDAddress: 22101 Moross Rd, PB2, Suite 70, Detroit, Michigan 48236Phone: 469-468-7978Fax: 313-343-4756Email:[email protected] Count: Main text: 841 wordsNumber of Tables: 0 Number of Figures: 0 Number of Supporting Information Files: 0Running Title: Remission in Infant ALL with Inotuzumab Ozogamicin.Keywords: Infant Leukemia, ALL Relapse, Immunotherapy